Education
About Us
Working with TipRanks
Follow Us
Zomedica (ZOMDF)
OTHER OTC:ZOMDF
ZOMDF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)10.01M
Market Cap
$47.53M
Enterprise Value$59.65M
Total Cash (Recent Filing)$12.95M
Total Debt (Recent Filing)$2.73M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
May 08, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding979,949,650
10 Day Avg. Volume1,931,929
30 Day Avg. Volume10,013,660
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.26
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.44
Enterprise Value/Ebitda-1.10
Forecast
1Y Price Target
$0.25Price Target Upside400.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Zomedica News
PremiumCompany Announcements
Zomedica’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Zomedica Achieves Record Revenue and Strategic Growth in 2024
PremiumCompany Announcements
Zomedica Reports Record Revenue and Strong Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.
Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.
Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.
Bears Say
Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.
Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.
---
Ownership Overview
2.29% Insiders
5.83% Mutual Funds
<0.01% Other Institutional Investors
87.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ZOMDF FAQ
What was Zomedica’s price range in the past 12 months?
Zomedica lowest stock price was $0.01 and its highest was $0.20 in the past 12 months.
What is Zomedica’s market cap?
Zomedica’s market cap is $47.53M.
When is Zomedica’s upcoming earnings report date?
Zomedica’s upcoming earnings report date is May 08, 2025 which is in 22 days.
How were Zomedica’s earnings last quarter?
Zomedica released its earnings results on Mar 13, 2025. The company reported -$0.007 earnings per share for the quarter, the consensus estimate of -$0.007 by $0.
Is Zomedica overvalued?
According to Wall Street analysts Zomedica’s price is currently Undervalued.
Does Zomedica pay dividends?
Zomedica does not currently pay dividends.
What is Zomedica’s EPS estimate?
Zomedica’s EPS estimate is >-0.01.
How many shares outstanding does Zomedica have?
Zomedica has 979,949,650 shares outstanding.
What happened to Zomedica’s price movement after its last earnings report?
Zomedica reported an EPS of -$0.007 in its last earnings report, expectations of -$0.007. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Zomedica?
Currently, no hedge funds are holding shares in ZOMDF
---
Zomedica Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.25 (400.00% Upside)
$0.25 (400.00% Upside)
Blogger Sentiment
Bullish
ZOMDF Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $263.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days <0.1%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.44%
12-Months-Change
Fundamentals
Return on Equity
-21.57%
Trailing 12-Months
Asset Growth
-18.10%
Trailing 12-Months
Company Description
Zomedica
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.
---
ZOMDF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Zomedica's earnings call highlighted strong revenue growth, especially in the diagnostics segment, and successful international expansion. However, these positives were countered by significant challenges, including the delisting from the NYSE and an increased net loss. The company's strong liquidity position and product innovation are promising, but these are tempered by market and operational challenges.Read More>---
ZOMDF Stock 12 Month Forecast
Average Price Target
$0.25
▲(400.00% Upside)
Technical Analysis
Cyclacel Pharmaceuticals
―
Bluebird Bio
―
VolitionRX
―
Serina Therapeutics
―
Acrivon Therapeutics, Inc.
―
Best Analysts Covering ZOMDF
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-37.87%
reiterated a buy rating last month
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -37.87% per trade.
---